APO RESEARCH · REPORT
Neuroscience
neurological disorders and the essence of human/animal behaviors and cognition. The key question of neuroscience is, as a branch of biology, to understand human neural activities, including learning, memory, attention, awareness, language, thinking and decision making, etc. As a branch of medicine, neuroscience addresses basic issues underlying neuropsychiatric disorders and interventions.
Product & engineering
Understand the product.
neurological disorders and the essence of human/animal behaviors and cognition. The key question of neuroscience is, as a branch of biology, to understand human neural activities, including learning, memory, attention, awareness, language, thinking and decision making, etc. As a branch of medicine, neuroscience addresses basic issues underlying neuropsychiatric disorders and interventions.
Selected research
Industry Research
Neuroscience Industry Research Report 2026
Market perspective
neurological disorders and the essence of human/animal behaviors and cognition. The key question of neuroscience is, as a branch of biology, to understand human neural activities, including learning, memory, attention, awareness, language, thinking and decision making, etc. As a branch of medicine, neuroscience addresses basic issues underlying neuropsychiatric disorders and interventions.
Global neuroscience main manufactuers include Siemens Healthineers, GE Healthcare, etc. The top 3 companies hold a share about 17%. Americas is the largest market of neuroscience, with a share about 40%, followed by Europe and Asia-Pacific.
Report Scope
Read the full market overview
This report quantifies the global Neuroscience market in terms of revenue (US$ million) and, where applicable, service volume (Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Neuroscience.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neuroscience Market by Company
Siemens Healthineers
GE Healthcare
Philips
Canon
Hitachi
Medtronic
Leica Microsystems
Zeiss
Nikon
JEOL Ltd
Natus Medical
Nihon Kohden
NeuroPace Inc
Shimadzu Corporation
Compumedics
Neuroscience Segment by Type
Instrument and Consumables
Software
Services
Neuroscience Segment by Application
Academic Institutes
Hospital
Research Institutes
Others
Neuroscience Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuroscience market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neuroscience and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuroscience.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Neuroscience companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Instrument and Consumables
- Software
- Services
Applications
- Academic Institutes
- Hospital
- Research Institutes
- Others
Companies covered
- Siemens Healthineers
- GE Healthcare
- Philips
- Canon
- Hitachi
- Medtronic
- Leica Microsystems
- Zeiss
- Nikon
- JEOL Ltd
- Natus Medical
- Nihon Kohden
- NeuroPace Inc
- Shimadzu Corporation
- Compumedics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Neuroscience by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Instrument and Consumables
- 2.2.3 Software
- 2.2.4 Services
- 2.3 Neuroscience by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Academic Institutes
- 2.3.3 Hospital
- 2.3.4 Research Institutes
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Neuroscience Breakdown Data by Type
- 3.1 Global Neuroscience Historic Market Size by Type (2021-2026)
- 3.2 Global Neuroscience Forecasted Market Size by Type (2027-2032)
4 Neuroscience Breakdown Data by Application
- 4.1 Global Neuroscience Historic Market Size by Application (2021-2026)
- 4.2 Global Neuroscience Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Neuroscience Market Perspective (2021-2032)
- 5.2 Global Neuroscience Growth Trends by Region
- 5.2.1 Global Neuroscience Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Neuroscience Historic Market Size by Region (2021-2026)
- 5.2.3 Neuroscience Forecasted Market Size by Region (2027-2032)
- 5.3 Neuroscience Market Dynamics
- 5.3.1 Neuroscience Industry Trends
- 5.3.2 Neuroscience Market Drivers
- 5.3.3 Neuroscience Market Challenges
- 5.3.4 Neuroscience Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Neuroscience Players by Revenue
- 6.1.1 Global Top Neuroscience Players by Revenue (2021-2026)
- 6.1.2 Global Neuroscience Revenue Market Share by Players (2021-2026)
- 6.2 Global Neuroscience Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Neuroscience Head Office and Area Served
- 6.4 Global Neuroscience Players, Product Type & Application
- 6.5 Global Neuroscience Manufacturers Established Date
- 6.6 Global Neuroscience Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Neuroscience Market Size (2021-2032)
- 7.2 North America Neuroscience Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Neuroscience Market Size by Country (2021-2026)
- 7.4 North America Neuroscience Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Neuroscience Market Size (2021-2032)
- 8.2 Europe Neuroscience Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Neuroscience Market Size by Country (2021-2026)
- 8.4 Europe Neuroscience Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Neuroscience Market Size (2021-2032)
- 9.2 Asia-Pacific Neuroscience Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Neuroscience Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Neuroscience Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Neuroscience Market Size (2021-2032)
- 10.2 South America Neuroscience Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Neuroscience Market Size by Country (2021-2026)
- 10.4 South America Neuroscience Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Neuroscience Market Size (2021-2032)
- 11.2 Middle East & Africa Neuroscience Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Neuroscience Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Neuroscience Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Siemens Healthineers
- 12.1.1 Siemens Healthineers Company Information
- 12.1.2 Siemens Healthineers Business Overview
- 12.1.3 Siemens Healthineers Revenue in Neuroscience Business (2021-2026)
- 12.1.4 Siemens Healthineers Neuroscience Product Portfolio
- 12.1.5 Siemens Healthineers Recent Developments
- 12.2 GE Healthcare
- 12.2.1 GE Healthcare Company Information
- 12.2.2 GE Healthcare Business Overview
- 12.2.3 GE Healthcare Revenue in Neuroscience Business (2021-2026)
- 12.2.4 GE Healthcare Neuroscience Product Portfolio
- 12.2.5 GE Healthcare Recent Developments
- 12.3 Philips
- 12.3.1 Philips Company Information
- 12.3.2 Philips Business Overview
- 12.3.3 Philips Revenue in Neuroscience Business (2021-2026)
- 12.3.4 Philips Neuroscience Product Portfolio
- 12.3.5 Philips Recent Developments
- 12.4 Canon
- 12.4.1 Canon Company Information
- 12.4.2 Canon Business Overview
- 12.4.3 Canon Revenue in Neuroscience Business (2021-2026)
- 12.4.4 Canon Neuroscience Product Portfolio
- 12.4.5 Canon Recent Developments
- 12.5 Hitachi
- 12.5.1 Hitachi Company Information
- 12.5.2 Hitachi Business Overview
- 12.5.3 Hitachi Revenue in Neuroscience Business (2021-2026)
- 12.5.4 Hitachi Neuroscience Product Portfolio
- 12.5.5 Hitachi Recent Developments
- 12.6 Medtronic
- 12.6.1 Medtronic Company Information
- 12.6.2 Medtronic Business Overview
- 12.6.3 Medtronic Revenue in Neuroscience Business (2021-2026)
- 12.6.4 Medtronic Neuroscience Product Portfolio
- 12.6.5 Medtronic Recent Developments
- 12.7 Leica Microsystems
- 12.7.1 Leica Microsystems Company Information
- 12.7.2 Leica Microsystems Business Overview
- 12.7.3 Leica Microsystems Revenue in Neuroscience Business (2021-2026)
- 12.7.4 Leica Microsystems Neuroscience Product Portfolio
- 12.7.5 Leica Microsystems Recent Developments
- 12.8 Zeiss
- 12.8.1 Zeiss Company Information
- 12.8.2 Zeiss Business Overview
- 12.8.3 Zeiss Revenue in Neuroscience Business (2021-2026)
- 12.8.4 Zeiss Neuroscience Product Portfolio
- 12.8.5 Zeiss Recent Developments
- 12.9 Nikon
- 12.9.1 Nikon Company Information
- 12.9.2 Nikon Business Overview
- 12.9.3 Nikon Revenue in Neuroscience Business (2021-2026)
- 12.9.4 Nikon Neuroscience Product Portfolio
- 12.9.5 Nikon Recent Developments
- 12.10 JEOL Ltd
- 12.10.1 JEOL Ltd Company Information
- 12.10.2 JEOL Ltd Business Overview
- 12.10.3 JEOL Ltd Revenue in Neuroscience Business (2021-2026)
- 12.10.4 JEOL Ltd Neuroscience Product Portfolio
- 12.10.5 JEOL Ltd Recent Developments
- 12.11 Natus Medical
- 12.11.1 Natus Medical Company Information
- 12.11.2 Natus Medical Business Overview
- 12.11.3 Natus Medical Revenue in Neuroscience Business (2021-2026)
- 12.11.4 Natus Medical Neuroscience Product Portfolio
- 12.11.5 Natus Medical Recent Developments
- 12.12 Nihon Kohden
- 12.12.1 Nihon Kohden Company Information
- 12.12.2 Nihon Kohden Business Overview
- 12.12.3 Nihon Kohden Revenue in Neuroscience Business (2021-2026)
- 12.12.4 Nihon Kohden Neuroscience Product Portfolio
- 12.12.5 Nihon Kohden Recent Developments
- 12.13 NeuroPace Inc
- 12.13.1 NeuroPace Inc Company Information
- 12.13.2 NeuroPace Inc Business Overview
- 12.13.3 NeuroPace Inc Revenue in Neuroscience Business (2021-2026)
- 12.13.4 NeuroPace Inc Neuroscience Product Portfolio
- 12.13.5 NeuroPace Inc Recent Developments
- 12.14 Shimadzu Corporation
- 12.14.1 Shimadzu Corporation Company Information
- 12.14.2 Shimadzu Corporation Business Overview
- 12.14.3 Shimadzu Corporation Revenue in Neuroscience Business (2021-2026)
- 12.14.4 Shimadzu Corporation Neuroscience Product Portfolio
- 12.14.5 Shimadzu Corporation Recent Developments
- 12.15 Compumedics
- 12.15.1 Compumedics Company Information
- 12.15.2 Compumedics Business Overview
- 12.15.3 Compumedics Revenue in Neuroscience Business (2021-2026)
- 12.15.4 Compumedics Neuroscience Product Portfolio
- 12.15.5 Compumedics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst